Coya Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Coya Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Coya Therapeutics Inc
Rating: 0.89408325
Author: Trendlyne DVM scores

about

Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune,...

4.21 -0.06 (-1.41%)

45.68% Fall from 52W High

142.0K

XNAS Volume

XNAS 20 Mar, 2026 5:30 PM (EDT)

Not Eligible

Expensive Valuation

6.3 / 100

Technically Bearish

29.4 / 100

1Yr Price target upside is 271%

7 analysts

Coya Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Coya Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune,...

45.68% Fall from 52W High

SWOT Analysis

Coya Therapeutics Inc Live Price Chart